0001209191-17-018270.txt : 20170306
0001209191-17-018270.hdr.sgml : 20170306
20170306160926
ACCESSION NUMBER: 0001209191-17-018270
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170302
FILED AS OF DATE: 20170306
DATE AS OF CHANGE: 20170306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP
CENTRAL INDEX KEY: 0000917520
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 510317849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
BUSINESS PHONE: 6092750500
MAIL ADDRESS:
STREET 1: 311 ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP
DATE OF NAME CHANGE: 19950614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy Raymond G.
CENTRAL INDEX KEY: 0001461806
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26224
FILM NUMBER: 17667951
MAIL ADDRESS:
STREET 1: 14604 CARROLTON ROAD
CITY: ROCKVILLE
STATE: MD
ZIP: 20853
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-02
0
0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP
IART
0001461806
Murphy Raymond G.
311 ENTERPRISE DRIVE
PLAINSBORO
NJ
08536
1
0
0
0
Common Stock
2017-03-02
4
M
0
5238
10.74
A
66132
D
Common Stock
2017-03-02
4
S
0
5238
43.0065
D
60894
D
Non-Qualified Stock Option (right to buy)
10.74
2017-03-02
4
M
0
5238
0.00
D
2017-05-20
Common Stock
5238
0
D
On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09.
25% of the stock options vested every quarter from the grant date of 5/20/2009.
This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
/s/ Richard D. Gorelick; Attorney-in-Fact
2017-03-06
EX-24.4_709619
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby authorizes Amritpal
Deol, Lisa Evoli, Richard D. Gorelick, Mythili Seshan, David Sirolly and Barbara
Vietor to execute for and on behalf of the undersigned Forms 3, 4 and 5, and any
amendments thereto, and cause such form(s) to be filed with the United States
Securities and Exchange Commission pursuant to Section 16(a) of the Securities
Act of 1934, relating to the undersigned's beneficial ownership of securities in
Integra LifeSciences Holdings Corporation (the "Company"). The undersigned also
authorizes the above persons to execute for and on behalf of the undersigned any
Form ID or similar document required to obtain or renew Securities and Exchange
Commission electronic filings codes and passwords and cause such form(s) to be
submitted to and/or filed with the Securities and Exchange Commission. The
undersigned hereby grants to each such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 6th day of March, 2017.
/s/ Raymond Murphy
Raymond Murphy